Literature DB >> 147420

Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.

P Stastny.   

Abstract

Previous testing of patients with rheumatoid arthritis showed that one HLA-D type, Dw4, occurred more frequently than in normal controls. B-cell alloantigens closely related to HLA-D can now be identified by a simple serologic procedure. Using this test, I studied 80 white patients with erosive, rheumatoid-factor-positive rheumatoid arthritis. The B-cell alloantigen HLA-DRw4 occurred in 70 per cent of 54 patients, as compared to 28 per cent of the 68 normal controls (P less than 10(-5)). Both groups were also tested for the HLA-A, B and C antigens and for HLA-D. HLA-Dw4 occurred in 54 per cent of the patients and 16 per cent of the controls (P less than 10(-5)). Small differences observed in several of the HLA-A and B antigens were not statistically significant. The results indicate that rheumatoid arthritis in whites is associated with genes of the HLA-D region and that immunogenetic factors linked to HLA have a role in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 147420     DOI: 10.1056/NEJM197804202981602

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  277 in total

1.  HLA-DR4 and the spondyloarthropathies.

Authors:  J D Taurog
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

2.  Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion.

Authors:  M J Leandro; J C W Edwards; G Cambridge
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

Review 3.  The immunogenetics of rheumatoid arthritis.

Authors:  B P Wordsworth; J I Bell
Journal:  Springer Semin Immunopathol       Date:  1992

4.  The diabetogenic mouse MHC class II molecule I-Ag7 is endowed with a switch that modulates TCR affinity.

Authors:  Kenji Yoshida; Adam L Corper; Rana Herro; Bana Jabri; Ian A Wilson; Luc Teyton
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

5.  Rationale for thymopentin as therapeutic agent in rheumatoid arthritis.

Authors:  P Franchimont; K Bolla
Journal:  Surv Immunol Res       Date:  1985

6.  Tumor necrosis factor alpha -308 polymorphism is associated with rheumatoid arthritis in Han population of Eastern China.

Authors:  Ruiwen Chen; Meng Fang; Qing Cai; Shiwei Duan; Ke Lv; Ning Cheng; Daming Ren; Jie Shen; Dongyi He; Lin He; Shuhan Sun
Journal:  Rheumatol Int       Date:  2007-08-21       Impact factor: 2.631

7.  The Swedish childhood diabetes study--results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders.

Authors:  G Dahlquist; L Blom; T Tuvemo; L Nyström; A Sandström; S Wall
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

8.  HLA DR antigens and disease expression in rheumatoid arthritis.

Authors:  A J Griffin; P Wooley; G S Panayi; J R Batchelor
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

9.  Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis.

Authors:  J J Goronzy; P Bartz-Bazzanella; W Hu; M C Jendro; D R Walser-Kuntz; C M Weyand
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

10.  Investigation of the HLA component involved in rheumatoid arthritis (RA) by using the marker association-segregation chi-square (MASC) method: rejection of the unifying-shared-epitope hypothesis.

Authors:  M H Dizier; J F Eliaou; M C Babron; B Combe; J Sany; J Clot; F Clerget-Darpoux
Journal:  Am J Hum Genet       Date:  1993-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.